Author:
Franklin Barry A.,Faitel Kathy,Hendrickson Kirk,Miller Wendy M.
Publisher
Springer International Publishing
Reference62 articles.
1. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2016 executive summary. Endocr Pract. 2016;22:84–113.
2. Franklin BA, Miller WM, Juliao TR. Effect of lifestyle interventions on coronary heart disease risk in patients with diabetes. In: DK MG, Marx N, editors. Diabetes in cardiovascular disease. Philadelphia: Elsevier Saunders, Philadelphia; 2015.
3. Reusch JE, Wang CC. Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab. 2011;96:2367–76.
4. American Diabetes Association. Microvascular complications and foot care. Diabetes Care. 2015;38(Suppl 1):S58–66.
5. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629–36.